Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Tetra Bio Pharma Inc TBPMQ

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.


GREY:TBPMQ - Post by User

Comment by SamV21on Nov 09, 2021 10:20am
96 Views
Post# 34104492

RE:You do not have Orphan Drug Designation yet , more lies.

RE:You do not have Orphan Drug Designation yet , more lies. No way of knowing if Reduvo will be approved, no one seems to know who is making the drug for Tetra, where it is made and how much it will cost to make.Know one knows if phase 2 trails will be successful , 70 % of all companies make it this far. .How does anyone know if there is any profit for shareholders and Qixleef application for orphan drug waiting  for an answer , means nothing, will not change anything short term.Orphan drug applications are granted for drugs that are assumed to be useful but most likely not profitable.It will save the company money but does not speed up approval , still has to go through all the phases and studies, no short cuts , just a cheaper way to go for the company to reduce cash burn.Most companies get knocked off the board Phase 2 trials  ,  Shorted sell off today , .21 cents here we come, that feeling you are having lately is most likely constipation, drink more water, it ain't tetra going up any time soon on nothing and no results.Wait for results , you said the stock was cheap at .40 cents you pumper,when we were at .50 last run you were predicting .75 then a dollar by month end over nothing and here you are again  pretending you know more than the company does.Just takes away from any honesty here.Wait for results , stop the uninformed hype we don't need another pump and dump.

<< Previous
Bullboard Posts
Next >>